These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26585562)

  • 1. POTENTIAL FOR PATIENTS AND PATIENT-DRIVEN ORGANIZATIONS TO IMPROVE EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT.
    Low E
    Int J Technol Assess Health Care; 2015 Jan; 31(4):226-7. PubMed ID: 26585562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments.
    Facey KM; Bedlington N; Berglas S; Bertelsen N; Single ANV; Thomas V
    Patient; 2018 Dec; 11(6):581-589. PubMed ID: 30051315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.
    Garfield S; Polisena J; S Spinner D; Postulka A; Y Lu C; Tiwana SK; Faulkner E; Poulios N; Zah V; Longacre M
    Value Health; 2016; 19(5):577-87. PubMed ID: 27565275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Danish Health Technology Assessment model. A systematic review of Danish HTAs published by CEMTV from 1998 to 2004].
    Draborg EU
    Ugeskr Laeger; 2006 May; 168(21):2074-8. PubMed ID: 16768927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT.
    Facey K; Henshall C; Sampietro-Colom L; Thomas S
    Int J Technol Assess Health Care; 2015 Jan; 31(4):201-6. PubMed ID: 26646858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the quality of mini-HTA.
    Kidholm K; Ehlers L; Korsbek L; Kjaerby R; Beck M
    Int J Technol Assess Health Care; 2009 Jan; 25(1):42-8. PubMed ID: 19126250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
    Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
    ; Neumann PJ; Drummond MF; Jönsson B; Luce BR; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2010 Jan; 26(1):71-8. PubMed ID: 20059783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stories of Patient Involvement Impact in Health Technology Assessments: A Discussion Paper.
    Single ANV; Facey KM; Livingstone H; Silva AS
    Int J Technol Assess Health Care; 2019; 35(4):266-272. PubMed ID: 31337453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
    Ascef BO; Silva RGLD; Oliveira Júnior HA; Soárez PC
    Cad Saude Publica; 2019 Sep; 35(9):e00087219. PubMed ID: 31531516
    [No Abstract]   [Full Text] [Related]  

  • 12. Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story.
    Norburn L; Thomas L
    Int J Technol Assess Health Care; 2020 Nov; 37():e15. PubMed ID: 33168114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international survey of the public engagement practices of health technology assessment organizations.
    Whitty JA
    Value Health; 2013; 16(1):155-63. PubMed ID: 23337227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on Health Technology Assessment (HTA): Good Practices & Principles. FIFARMA's Position on HTA Processes in Latin America: The Devil Is in the Details.
    Levy A
    Value Health Reg Issues; 2017 Dec; 14():53-56. PubMed ID: 29254542
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of patient and public participation in health technology assessment and coverage decisions.
    Menon D; Stafinski T
    Expert Rev Pharmacoecon Outcomes Res; 2011 Feb; 11(1):75-89. PubMed ID: 21351860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment use and dissemination by patient and consumer groups: why and how?
    Fattal J; Lehoux P
    Int J Technol Assess Health Care; 2008; 24(4):473-80. PubMed ID: 18828943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic data transferability for HTA: are we there yet?
    Manca A
    Value Health; 2009 Jun; 12(4):407. PubMed ID: 19900247
    [No Abstract]   [Full Text] [Related]  

  • 19. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.